StockData
BioLineRx Ltd. logo

BioLineRx Ltd. (BLRX) stock

BLRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 23, 2026Score 3/30
$1.12−0.03 (-2.61%)

Close on Nov 17, 2026Market cap $4.87MP/E –Yield –

BioLineRx operating margin

Operating margin is operating income as a percentage of revenue.

For fiscal 2025 it was -871.8%, against -70.5% the year before.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-871.8%−801.3
FY2024Dec 31, 2024-70.5%+964.8
FY2023Dec 31, 2023-1035.3%–

Quarterly operating margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 2026-1215.3%–
Q2 FY2025Jun 30, 2025-757.6%–
Q2 FY2024Jun 30, 2024-107.0%–

More BioLineRx figures

See a number that looks wrong?